Although there was a trend to a reduction in myocardial fibrosis with DUSP5 siRNA+T3 treatment, this failed to reach statistical significance ( Figure S7 ).
← all excerpts
Thyroid hormone plus dual-specificity phosphatase-5 siRNA increases the number of cardiac muscle cells and improves left ventricular contractile function in chronic doxorubicin-injured hearts.
1
—
—